[1] ZHOU S F,ESTRERA A L,LOUBSER P,et al.Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair:a prospective,randomized,controlled trial[J].Ann Thorac Surg,2015,99(4):1282-1290. [2] 黄枭,罗婷,吴安石.围术期血小板输注的研究进展[J].临床麻醉学杂志,2020,36(4):401-403. [3] TONG J, CAO L, LIU L, et al.Impact of autologous platelet rich plasma use on postoperative acute kidney injury in type A acute aortic dissection repair: a retrospective cohort analysis[J].J Cardiothorac Surg.2021.16(1): 9. [4] 邓丽,刘宗泓,杨慧,等.自体血小板分离回输减少主动脉夹层手术围术期异体血制品用量[J].中国体外循环杂志,2016,14(4):205-208. [5] SAFWAT A M,BUSH R,PREVEC W,et al.Intraoperative use of platelet-plasmapheresis in vascular surgery[J].J Clin Anesth,2002,14(1):10-14. [6] 汪雍媛,纪宏文.自体血小板分离对深低温停循环主动脉手术的血液保护作用[J].中国输血杂志,2016,29(4):441-444. [7] SANDHU H K,TANAKA A,DAHOTRE S,et al.Propensit y and impact of autologous platelet rich plasma use in acute type A dissection[J].J Thorac Cardiovasc Surg,2020,159(6):2288-2297.e1. [8] 金祺,李呈龙,樊凡,等.急性A型主动脉夹层患者围术期血小板动态变化与预后相关性分析[J].心肺血管病杂志,2020,39(2):173-177. [9] NAEEM S S,SODHA N R,SELLKE F W,et al.Impact of packed red blood cell and platelet transfusions in patients undergoing dissection repair[J].J Surg Res,2018,232:338-345. [10] ZHOU X,FRASER C,SUAREZ-PIERRE A,et al.Variation in platelet transfusion practices in cardiac surgery[J].Innov,2019,14:134-143. [11] 王晓敏, 林春, 陈关海, 吴柱国.主动脉夹层发病机制的研究进展.海南医学. 2019.30(06): 792-795. [12] 杨燕,熊剑秋.影响Stanford A型主动脉夹层患者术前猝死的因素及护理对策[J].护理实践与研究,2018,15(2):71-72. [13] 王登峰,张超,韩冬,等.Stanford A型急性主动脉夹层孙氏手术后低氧血症危险因素探讨[J].心肺血管病杂志,2021,40(1):53-55. [14] Transfusion of red blood cells,fresh frozen plasma,or platelets is associated with mortality and infection after cardiac surgery in a dose-dependent manner[J].Anesth Analg,2020,130(2):e32. [15] KOCH C G,LI L,DUNCAN A I,et al.Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting[J]. Crit Care Med,2006,34(6):1608-1616. [16] 孙子嫣. aPRP对A型主动脉夹层患者的血液保护和短期预后影响[D].天津医科大学,2020. |